IL-15 as a potential target in leukemia

Abstract : Leukemia, one of the most aggressive hematopoietic malignancies, is characterized by excessive proliferation, survival, and impaired differentiation of hematopoietic stem cells. Interleukin 15, a proinflammatory cytokine, induces proliferation and promotes cell survival of human T and B lymphocytes, as well as natural killer cells. However, it may also play a detrimental role in the onset of leukemia. This review provided an overview of the aberrant expression of Interleukin 15 and its role in the development and progression of this hematological malignancy. Also, we critically explored the potential therapeutic opportunities involved in targeting the disruption of interleukin-15 signaling as well as in interleukin-15-mediated enhancement of antitumor immunity.
Liste complète des métadonnées

Littérature citée [87 références]  Voir  Masquer  Télécharger
Contributeur : Imopa Ul <>
Soumis le : vendredi 10 février 2017 - 11:43:33
Dernière modification le : jeudi 8 février 2018 - 15:56:35
Document(s) archivé(s) le : jeudi 11 mai 2017 - 13:04:40


Fichiers éditeurs autorisés sur une archive ouverte




Yu Xiong, Danièle Bensoussan, Véronique Decot. IL-15 as a potential target in leukemia. Blood and lymphatic cancer: targets and therapy, Dove Medical Press, 2015, 5, pp.55—63. 〈〉. 〈10.2147/BLCTT.S78347〉. 〈hal-01464505〉



Consultations de la notice


Téléchargements de fichiers